Treatment outcome of multidrug-resistant tuberculosis in Japan - the first cross-sectional study of Japan tuberculosis surveillance data.
Lisa KawatsuKazuhiro UchimuraKiyohiko IzumiAkihiro OhkadoTakashi YoshiyamaPublished in: BMC infectious diseases (2018)
Increasing proportion of new cases, and of younger age groups among the MDR-TB patients indicate new transmissions. Better strategies for early detection and containment of MDR-TB are urgently needed. The overall treatment completion rate was 57.0% over the three-year study period. However, when restricting the result to those aged 64 years old and below, the rate improved to 71.6%, which was comparable to similarly industrialized countries. Due to the limitations of the JTBS data, a comprehensive survey of all MDR-TB patients may be necessary to provide more concrete evidence for decision-making.
Keyphrases
- multidrug resistant
- mycobacterium tuberculosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- decision making
- drug resistant
- electronic health record
- public health
- peritoneal dialysis
- emergency department
- big data
- hiv aids
- acinetobacter baumannii
- pulmonary tuberculosis
- escherichia coli
- cross sectional
- patient reported outcomes
- klebsiella pneumoniae
- artificial intelligence
- drug induced